Here are the details:
• Total revenue of $166.6M up 50% or 55% in constant currency
• Underlying EBITDA of $28.1M up 62%, statutory EBITDA of $22.2M up 29%
• Underlying NPAT of $19.7M up 86%, statutory NPAT of $14.3M up 36%
• Underlying EBITDA margin improvement from 15.6% in 2016 to 16.9% in 2017
• Strong cash conversion (75% of EBITDA)
• Full year underlying EBITDA for the financial year 2018, ending December 31st 2018, is currently forecast in the range of $50M-$55M (at A$1 = US$0.80)
The relentless high revenue growth continues unabated.
Here’s the three year chart:
A dream stock. Has anyone out there ridden this one all the way up?
Be the first to comment